Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension
Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension
复制标题
DOI：
10.1007/978-981-15-1185-1
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
T. Nakanishi;H. Baldwin;J. Fineman;H. Yamagishi
中科院分区：
文献类型：
--
作者：
T. Nakanishi;H. Baldwin;J. Fineman;H. Yamagishi
这本开放获取的书集中在先天性心脏病和肺动脉高压的分子机制，提供了新的见解肺循环和动脉导管的发展。它详细描述了参与心脏，肺和动脉导管的发育和形态发生的分子机制，涵盖了一系列主题，如基因功能，生长因子，转录因子和细胞相互作用，以及干细胞工程技术。这本书也介绍了我们对肺发育、肺动脉高压和动脉导管的分子调节的分子机制的理解的最新进展。因此，它是对先天性心脏病起源的最新发现和涉及肺循环/高血压和动脉导管的潜在未来治疗感兴趣的医生，科学家和研究人员的理想资源。
This open access book focuses on the molecular mechanism of congenital heart disease and pulmonary hypertension, offering new insights into the development of pulmonary circulation and the ductus arteriosus. It describes in detail the molecular mechanisms involved in the development and morphogenesis of the heart, lungs and ductus arteriosus, covering a range of topics such as gene functions, growth factors, transcription factors and cellular interactions, as well as stem cell engineering technologies. The book also presents recent advances in our understanding of the molecular mechanism of lung development, pulmonary hypertension and molecular regulation of the ductus arteriosus. As such, it is an ideal resource for physicians, scientists and investigators interested in the latest findings on the origins of congenital heart disease and potential future therapies involving pulmonary circulation/hypertension and the ductus arteriosus.